Kanni T, Argyropoulou M, Dinarello CA, Simard J, et al. MABp1 targeting interleukin-1alpha in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period. Clin Exp Dermatol 2021;46:162-163.
PMID: 32516832